OpEd: U.S. Senate does right by not limiting patent damages

after a very large judgment in a patent infringement case?such as the $1.67-billion verdict against North Chicago-based Abbott Laboratories in 2009 involving its Humira arthritis drug?public calls for patent reform and reactions from Congress follow....